Loading organizations...
Kento Health develops an advanced digital therapeutics platform focused on continuous cardiovascular care. The company leverages artificial intelligence, clinical expertise, and evidence-based behavioral science to deliver personalized programs designed for cardiac rehabilitation and chronic heart condition management. This integrated platform aims to proactively monitor patient health signals and facilitate early interventions, supporting individuals in maintaining heart health.
The company was co-founded in 2022 by Max Leca, Mike Furino, and Jonah Davies. Their collective experience, particularly from their previous roles at Dialogue Health, informed the foundational insight for Kento. Recognizing the limitations and accessibility gaps in traditional cardiac care, they set out to create a more scalable and personalized solution that could reach a broader population.
Kento Health primarily serves individuals navigating recovery from cardiac events or living with ongoing heart disease, working in collaboration with leading healthcare institutions. Its overarching vision is to fundamentally transform cardiovascular health outcomes. By making advanced cardiac care more accessible and engaging, Kento Health strives to diminish heart disease’s prevalence as a primary cause of mortality and enhance the overall quality of life for its users.
Kento Health has raised $6.0M across 1 funding round.
Kento Health has raised $6.0M in total across 1 funding round.
Kento Health has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in October 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2023 | $6M Seed | Boreal Ventures, N49p Ventures | Harvest Venture Partners, Highline Beta Inc., High Line Venture Partners, Broom Ventures, Graphite Ventures | Announced |
Kento Health has raised $6.0M in total across 1 funding round.
Kento Health's investors include Boreal Ventures, N49P Ventures, Harvest Venture Partners, Highline Beta Inc., High Line Venture Partners, Broom Ventures, Graphite Ventures.
# Kento Health: High-Level Overview
Kento Health is an AI-powered digital cardiac rehabilitation and heart care platform that helps patients recover from major cardiac events and manage cardiovascular diseases[1]. Founded in 2022 and based in Montreal, Canada, the company serves health systems, providers, health plans, employers, and patients directly[1].
The platform delivers personalized clinical exercise plans, real-time heart monitoring, coaching, and continuous care coordination through a combination of AI-driven personalization and certified specialist support[2]. Kento's core value proposition centers on improving patient outcomes while reducing hospitalizations and expanding revenue opportunities for health systems—the company reports up to 3x higher enrollment rates, 95% adherence, and up to 2.5x ROI from expanded cardiac programs[2].
# Origin Story
Kento Health emerged in 2022 as a response to gaps in cardiac rehabilitation accessibility and engagement. The company distinguished itself early through a strategic partnership with Mayo Clinic, which co-developed the platform[4]. This partnership provided clinical credibility and domain expertise that shaped the product's architecture from inception. The company closed a $4.1 million CAD ($3 million USD) pre-seed financing round, signaling investor confidence in the digital cardiac care market[1].
# Core Differentiators
# Role in the Broader Tech Landscape
Kento operates within the digital health transformation trend, specifically addressing the shift toward remote monitoring and continuous care models. The timing is critical: health systems face mounting pressure to reduce readmissions, improve HEDIS/Star ratings, and expand revenue through value-based care models. Kento's AI-driven approach aligns with broader healthcare industry movement toward personalized medicine and home-based care delivery.
The company also reflects growing recognition that chronic disease management requires behavioral engagement, not just clinical intervention. By combining real-time monitoring with AI-powered personalization and human coaching, Kento addresses a market gap where traditional cardiac rehabilitation programs struggle with enrollment and adherence. Its success influences how health systems think about scaling specialized care programs beyond traditional in-clinic models.
# Quick Take & Future Outlook
Kento Health is positioned at the intersection of three powerful trends: the shift to remote care, the adoption of AI in clinical decision-making, and the healthcare industry's focus on reducing preventable hospitalizations. The company's early traction—demonstrated through health system partnerships and measurable outcome improvements—suggests strong product-market fit in a high-stakes clinical domain.
Looking forward, Kento's growth will likely depend on expanding beyond cardiac rehabilitation into broader cardiovascular disease management and chronic condition monitoring. The Mayo Clinic partnership provides a foundation for clinical validation that could accelerate adoption across larger health systems. As value-based care models become standard, platforms that demonstrably reduce readmissions and improve outcomes while improving operational efficiency will become essential infrastructure rather than optional tools.
